Geron Corporation (0IV3.L) Stock Price
$1.31 0.8%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
1 -
Technical
4
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Geron Corporation, AI stock picks, stock alerts and much more.
0IV3.L AI Stock Analysis
AI stock analysis for 0IV3.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Geron Corporation (0IV3.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Geron Corporation (0IV3.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Geron Corporation (0IV3.L), currently trading at $1.31, will... Sign up to access price prediction.
About 0IV3.L
-
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies.
-
Symbol
0IV3.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
832.6M
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$386.5 1.6% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$144.3 1.1% |
6 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$7.92 0.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.71 1.6% |
4 |
 |
Esperion Therapeutics 0IIM.L |
$2.75 0.2% |
6 |
News
0IV3.L Alternative Data
Web Traffic
Geron Corporation receives an estimated 18456 monthly visitors to geron.com.
-
Web Traffic
18456
-
Change from Previous Month
52.3%
-
3 Month Change
62.4%
-
YoY Change
62.4%
Job Postings
Geron Corporation has an estimated 7 open job postings, which is down -36.4% over the last month.
-
Job Postings
7
-
Daily Change
0%
-
1 Month Change
36.4%
-
3 Month Change
75%
-
YoY Change
75%
Reddit Mentions
Geron Corporation has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
20,594 are following Geron Corporation on LinkedIn, up by 1.8% over the last month.
-
LinkedIn Followers
20594
-
Daily Change
1.8%
-
1 Month Change
1.8%
-
3 Month Change
11.9%
-
YoY Change
11.9%
LinkedIn Employees
According to LinkedIn, Geron Corporation has 411 employees, up by 1.5% over the last month.
-
LinkedIn Employees
411
-
Daily Change
1.5%
-
1 Month Change
1.5%
-
3 Month Change
5.1%
-
YoY Change
5.1%
Business Outlook
According to employee reviews, the business outlook among employees at Geron Corporation is 49 out of 100 (neutral).
-
Business Outlook
49
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Geron Corporation was mentioned 4 times in the news yesterday.
-
News Mentions
4
-
Daily Change
33.3%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0IV3.L Financials
0IV3.L Key Metrics
-
Total Revenue
$39.6M
-
Net Income
-$19.8M
-
Earnings per Share
-$0.03
-
Free cash flow
-$48M
-
EBITDA
-$16.7M
-
EBITDA Ratio
-0.421786
-
Total Assets
$562.5M
0IV3.L 2-year Revenue & Income
0IV3.L 2-year Free Cash Flow
0IV3.L Technicals
0IV3.L SMA
0IV3.L RSI
FAQ
What's the current price of Geron Corporation (0IV3.L) Stock?
The price of an Geron Corporation (0IV3.L) share is $1.31.
What's the market cap of Geron Corporation?
The current market cap of Geron Corporation is 832.6M.
What are some stocks similar to Geron Corporation (0IV3.L) that investors often compare it to?
Geron Corporation (0IV3.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Geron Corporation's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Geron Corporation's stock price to be around $1.3 in 2026. Starting from the current price of $1.31, this represents a 0.6% change in price, indicating a neutral outlook for the stock.
How to buy Geron Corporation (0IV3.L) Stock?
Geron Corporation stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Geron Corporation shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.